Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2016

01-11-2016 | Epidemiology

Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient

Authors: Thomas M. Churilla, Brian L. Egleston, Colin T. Murphy, Elin R. Sigurdson, Shelly B. Hayes, Lori J. Goldstein, Richard J. Bleicher

Published in: Breast Cancer Research and Treatment | Issue 1/2016

Login to get access

Abstract

Purpose

Multidisciplinary care (MDC) in managing breast cancer is resource-intensive and growing in prevalence anecdotally, although care patterns are poorly characterized. We sought to determine MDC patterns and effects on care in the United States Medicare patient.

Methods

Patients diagnosed with non-metastatic invasive breast cancer from 1992–2009 were reviewed using the Survival, Epidemiology, and End Results (SEER)-Medicare linked dataset. MDC was defined as a post-diagnosis, preoperative visit with a surgical, medical, and radiation oncologist. Same-day MDC (MDCSD) was the MDC subset having all three visits on one date.

Results

Among 88,865 patients, MDC was utilized in 2.9 %, with 14.1 % of these having MDCSD. MDC use did not vary by stage, but MDC patients were more likely to be younger, black, receive lumpectomy, have fewer nodes examined, and receive radiotherapy. MDCSD patients were more likely than non-MDC patients to be black, receive mastectomy, and receive radiotherapy. MDC and MDCSD use increased over time and varied by geographic region, with rural patients less likely to receive MDC (OR 0.54 [95 % CI 0.45–0.65]) and MDCSD (OR 0.32 [95 % CI 0.19–0.54]). Radiotherapy after breast conserving surgery, used in 86.5 % of non-MDC patients, was administered to 90.2 % of MDC (p = 0.001) and 92.6 % of MDCSD (p = 0.019) patients. Post-mastectomy radiotherapy was administered in 52.0 % of non-MDC patients, 63.8 % of MDC (p = 0.050), and 89.1 % of MDCSD (p = 0.298) after propensity score adjustment.

Conclusion

While increasing, few Medicare patients undergo MDC and MDCSD is rare. MDC may improve quality and MDCSD should be considered for patient convenience. While not yet widespread, efforts should integrate MDC and MDCSD across the U.S.
Appendix
Available only for authorised users
Literature
1.
go back to reference Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Peto R, Davies C et al (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet Lond Engl 379:432–444. doi:10.1016/S0140-6736(11)61625-5 CrossRef Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Peto R, Davies C et al (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet Lond Engl 379:432–444. doi:10.​1016/​S0140-6736(11)61625-5 CrossRef
2.
go back to reference EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet Lond Engl 383:2127–2135. doi:10.1016/S0140-6736(14)60488-8 CrossRef EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet Lond Engl 383:2127–2135. doi:10.​1016/​S0140-6736(14)60488-8 CrossRef
3.
go back to reference Baldwin L-M, Taplin SH, Friedman H, Moe R (2004) Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma? Cancer 100:701–709. doi:10.1002/cncr.20030 CrossRefPubMed Baldwin L-M, Taplin SH, Friedman H, Moe R (2004) Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma? Cancer 100:701–709. doi:10.​1002/​cncr.​20030 CrossRefPubMed
5.
go back to reference Gomella LG, Lin J, Hoffman-Censits J et al (2010) Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract Am Soc Clin Oncol 6:e5–e10. doi:10.1200/JOP.2010.000071 CrossRef Gomella LG, Lin J, Hoffman-Censits J et al (2010) Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract Am Soc Clin Oncol 6:e5–e10. doi:10.​1200/​JOP.​2010.​000071 CrossRef
6.
go back to reference Chang JH, Vines E, Bertsch H et al (2001) The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer 91:1231–1237CrossRefPubMed Chang JH, Vines E, Bertsch H et al (2001) The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer 91:1231–1237CrossRefPubMed
7.
go back to reference Korman H, Lanni T, Shah C et al (2013) Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience. Am J Clin Oncol 36:121–125. doi:10.1097/COC.0b013e318243708f CrossRefPubMed Korman H, Lanni T, Shah C et al (2013) Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience. Am J Clin Oncol 36:121–125. doi:10.​1097/​COC.​0b013e318243708f​ CrossRefPubMed
8.
9.
go back to reference Gabel M, Hilton NE, Nathanson SD (1997) Multidisciplinary breast cancer clinics. Do they work? Cancer 79:2380–2384CrossRefPubMed Gabel M, Hilton NE, Nathanson SD (1997) Multidisciplinary breast cancer clinics. Do they work? Cancer 79:2380–2384CrossRefPubMed
10.
go back to reference Devitt B, Philip J, McLachlan S-A (2010) Team dynamics, decision making, and attitudes toward multidisciplinary cancer meetings: health professionals’ perspectives. J Oncol Pract Am Soc Clin Oncol 6:e17–e20. doi:10.1200/JOP.2010.000023 CrossRef Devitt B, Philip J, McLachlan S-A (2010) Team dynamics, decision making, and attitudes toward multidisciplinary cancer meetings: health professionals’ perspectives. J Oncol Pract Am Soc Clin Oncol 6:e17–e20. doi:10.​1200/​JOP.​2010.​000023 CrossRef
11.
go back to reference Bunnell CA, Weingart SN, Swanson S et al (2010) Models of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center. J Oncol Pract Am Soc Clin Oncol 6:283–288. doi:10.1200/JOP.2010.000138 CrossRef Bunnell CA, Weingart SN, Swanson S et al (2010) Models of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center. J Oncol Pract Am Soc Clin Oncol 6:283–288. doi:10.​1200/​JOP.​2010.​000138 CrossRef
12.
go back to reference American College of Surgeons (2014)interdisciplinary patient management Section 2.1. national accreditation program for breast centers. Standard Manual, Chicago. American College of Surgeons (2014)interdisciplinary patient management Section 2.1. national accreditation program for breast centers. Standard Manual, Chicago.
16.
17.
go back to reference Robins JM, Hernán MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiol Camb Mass 11:550–560CrossRef Robins JM, Hernán MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiol Camb Mass 11:550–560CrossRef
18.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27CrossRefPubMed Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27CrossRefPubMed
20.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
22.
go back to reference Harrell FE Jr (2001) General aspects of fitting regression models. In: regression modeling strategies. Springer, New York, pp 11–40CrossRef Harrell FE Jr (2001) General aspects of fitting regression models. In: regression modeling strategies. Springer, New York, pp 11–40CrossRef
23.
go back to reference European Partnership Action Against Cancer consensus group, Borras JM, Albreht T et al (2014) Policy statement on multidisciplinary cancer care. Eur J Cancer Oxf Engl 1990(50):475–480. doi:10.1016/j.ejca.2013.11.012 European Partnership Action Against Cancer consensus group, Borras JM, Albreht T et al (2014) Policy statement on multidisciplinary cancer care. Eur J Cancer Oxf Engl 1990(50):475–480. doi:10.​1016/​j.​ejca.​2013.​11.​012
25.
Metadata
Title
Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient
Authors
Thomas M. Churilla
Brian L. Egleston
Colin T. Murphy
Elin R. Sigurdson
Shelly B. Hayes
Lori J. Goldstein
Richard J. Bleicher
Publication date
01-11-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3982-x

Other articles of this Issue 1/2016

Breast Cancer Research and Treatment 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine